CTA
MEDP icon

Carillon Tower Advisers’s Medpace MEDP Stock Holding History

Carillon Tower Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$35.4M Buy
254,168
+194,961
+329% +$24.6M 0.22% 147
2020
Q3 		$6.62M Buy
59,207
+1,082
+2% +$125K 0.09% 301
2020
Q2 		$5.41M Buy
58,125
+2,800
+5% +$238K 0.04% 360
2020
Q1 		$4.06M Sell
55,325
-5,700
-9% -$495K 0.04% 349
2019
Q4 		$5.13M Sell
61,025
-2,000
-3% -$155K 0.03% 390
2019
Q3 		$5.3M Sell
63,025
-500
-0.8% -$37.8K 0.04% 385
2019
Q2 		$4.16M Buy
63,525
+4,575
+8% +$264K 0.03% 405
2019
Q1 		$3.48M Buy
58,950
+650
+1% +$38.8K 0.02% 415
2018
Q4 		$3.09M Buy
+58,300
New +$3.2M 0.03% 401

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Carillon Tower Advisers's MEDP Position: Q4 2020 in Review

Carillon Tower Advisers increased its Medpace (MEDP) stake by 329% in Q4 2020, buying an estimated $24.6M and bringing the position to 254,168 shares worth $35.4M. The position accounts for 0.22% of the portfolio, ranked #147.

Carillon Tower Advisers first reported a position in MEDP in Q4 2018 and has held it in 9 quarters since. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

  • Carillon Tower Advisers held 254,168 shares of Medpace worth $35.4M as of Q4 2020.
  • Carillon Tower Advisers bought 194,961 Medpace shares in Q4 2020, an estimated $24.6M.
  • Medpace made up 0.22% of Carillon Tower Advisers's portfolio in Q4 2020, its #147 holding.
  • Carillon Tower Advisers first reported a position in Medpace in Q4 2018 and has held it in 9 quarters since.
  • 316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.